HHS Secretary Kennedy Announces Conclusion of COVID-19 Emergency Use Authorization Declarations
-
By
-
Assistant Secretary for Public Affairs (ASPA)
-
June 30, 2026
Clinical Report: HHS Secretary Kennedy Announces Conclusion of COVID-19 EUA Declarations
Overview
The HHS has announced the termination of COVID-19 Emergency Use Authorization declarations for drugs, biological products, and medical devices, effective after specified notice periods.
Background
The COVID-19 Emergency Use Authorization (EUA) declarations were initially established to facilitate rapid access to medical products during the pandemic. As the availability of FDA-approved products has increased and reliance on EUA products has decreased, the need for these emergency authorities has diminished.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
- The COVID-19 EUA declarations were first issued in 2020 to enable rapid access to medical products.
- Secretary Robert F. Kennedy, Jr. has signed determinations to terminate these declarations, stating that the circumstances justifying them no longer exist.
- The termination for drugs and biological products will take effect 12 months after the determination, while medical devices will terminate 180 days later.
- HHS will publish notices of the terminations in the Federal Register and notify Congress as required by law.
- Advance notice periods are intended to allow an orderly transition for manufacturers and healthcare providers.
Clinical Implications
Manufacturers and healthcare providers should prepare for the transition away from products authorized solely under the COVID-19 EUA declarations.
Conclusion
The conclusion of the COVID-19 EUA declarations marks a transition to standard regulatory practices for medical products.
Related Resources & Content
- HHS Secretary Kennedy Signs COVID-19 Emergency Use Authorization Declaration Terminations | HHS.gov, 2026 -- HHS Successfully Concludes COVID-19 EUA Declarations
- ADA News — Federal COVID-19 emergency declarations set to expire May 11
- ADA News — CDC releases new guidance on broader masking in health care settings
- ada news — RFK Jr. confirmed as HHS secretary
- United States Department of Health and Human Services — HHS Successfully Concludes Hantavirus Response Effort; Monitoring Ends with No Positive U.S. Case
- Federal COVID-19 emergency declarations set to expire May 11
- CDC releases new guidance on broader masking in health care settings
- RFK Jr. confirmed as HHS secretary
- HHS Secretary Kennedy Signs COVID-19 Emergency Use Authorization Declaration Terminations | HHS.gov
- COVID-19 Treatment Clinical Care for Outpatients | Covid | CDC
- Nirmatrelvir/Ritonavir Efficacy in Immunocompetent Patients with Confirmed Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2: An Updated Systematic Review and Meta-analysis - PubMed
Based on findings from:
HHS Secretary Kennedy Signs COVID-19 Emergency Use Authorization Declaration Terminations
Assistant Secretary for Public Affairs (ASPA). United States Department Of Health And Human Services, 2026.
https://www.hhs.gov/press-room/hhs-ends-covid-19-emergency-use-authorizations.html
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
